Peptide Comparison
GHK vs Glow
Editorial breakdown of mechanism, evidence, decision criteria, and the misconceptions worth calling out.
Data-derived verdict
GHK and Glow share the matrikine class and carry roughly equivalent evidence (Preclinical + Cosmetic / Anecdotal). On the catalogued data layer GHK has a slight edge: more cited sources or efficacy data on file. For most research framings either pick is defensible; GHK's evidence base is currently denser.
Evidence at a glance
FDA-approved Phase 3 Phase 2 / approved abroad Anecdotal + animal Preclinical / flagged
Side-by-side
| GHK | Glow | |
|---|---|---|
| Class | Matrikine tripeptide; signaling/reparative | Three-component regenerative blend (matrikine + cytoprotective + actin-regulator) |
| Drug class | Tissue Repair | Tissue Repair |
| Mechanism | Modulates expression of hundreds of genes related to tissue repair; copper transport | Layered remodelling: GHK-Cu's copper-peptide matrikine signal upregulates collagen and elastin transcription and engages roughly 4,000 wound-healing genes; BPC-157 drives angiogenesis via VEGFR2 and stabilises epithelial / connective-tissue repair; TB-500 sequesters G-actin to enable cell migration and amplifies stem-cell mobilisation. Together: matrix synthesis + vessel-bed repair + cell-migration substrate. |
| Route | Topical / SC | SC injection |
| Half-life | Minutes (plasma) | Composite: hours (BPC-157 / GHK-Cu) to days (TB-500 tissue uptake) |
| Dosage (research) | 1-5 mg daily topical/SC (research) | Typical SC protocols deliver ~250-500 mcg per component daily for 4-6 week loading cycles. Confirm per-component dose from the vial total before reconstitution |
| Evidence tier | Preclinical + Cosmetic | Anecdotal |
| Research depth | 163 indexed | — |
| Availability | Research | Compounding Restricted |
| Reported risks | Less bioavailable than GHK-Cu; limited injectable human trials | No human trials of the combined formulation; TB-500 WADA-banned with theoretical pro-proliferative concerns; chronic GHK-Cu raises copper-accumulation considerations at high doses; injection-site reactions |
Reported research data only. "Studied for" and "reported in literature" describe published research focus, not clinical recommendation. Most peptides catalogued here are not FDA-approved for human use.
Frequently asked questions
Should I pick GHK or Glow?
GHK and Glow share the matrikine class and carry roughly equivalent evidence (Preclinical + Cosmetic / Anecdotal). On the catalogued data layer GHK has a slight edge: more cited sources or efficacy data on file. For most research framings either pick is defensible; GHK's evidence base is currently denser.
What is the difference between GHK and Glow?
GHK is classed as Matrikine tripeptide; signaling/reparative; Glow is classed as Three-component regenerative blend (matrikine + cytoprotective + actin-regulator). Reported mechanism: GHK, Modulates expression of hundreds of genes related to tissue repair; copper transport; Glow, Layered remodelling: GHK-Cu's copper-peptide matrikine signal upregulates collagen and elastin transcription and engages roughly 4,000 wound-healing genes; BPC-157 drives angiogenesis via VEGFR2 and stabilises epithelial / connective-tissue repair; TB-500 sequesters G-actin to enable cell migration and amplifies stem-cell mobilisation. Together: matrix synthesis + vessel-bed repair + cell-migration substrate. Reported half-life: GHK, Minutes (plasma); Glow, Composite: hours (BPC-157 / GHK-Cu) to days (TB-500 tissue uptake). Routes in published studies: GHK, Topical / SC; Glow, SC injection.
Which has stronger evidence, GHK or Glow?
Glow has the stronger evidence base on PeptideHelper.org's five-step evidence scale, which runs from preclinical to FDA-approved. GHK is graded Preclinical + Cosmetic, with 8 cited sources on its reference page and 163 indexed studies. Glow is graded Anecdotal, with 3 cited sources on its reference page.
Which is more accessible, GHK or Glow?
Neither GHK nor Glow is an FDA-approved drug. Catalog status: GHK, Research; Glow, Compounding Restricted.
Are GHK and Glow ever combined?
GHK and Glow appear together in no stack catalogued on PeptideHelper.org, and the interaction engine raises no flag for the pair.
Open the PeptideHelper.org compare tool to add more compounds to this side-by-side and filter by evidence tier interactively.
Loading interactive view…